HomeQLGN • NASDAQ
add
Qualigen Therapeutics Inc
Previous close
$3.35
Day range
$3.31 - $3.60
Year range
$1.61 - $10.45
Market cap
7.18M USD
Avg Volume
3.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.39M | 41.40% |
Net income | -1.69M | -6.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 331.60K | 179.40% |
Total assets | 3.96M | 641.50% |
Total liabilities | 5.61M | 16.68% |
Total equity | -1.65M | — |
Shares outstanding | 1.70M | — |
Price to book | -1.23 | — |
Return on assets | -103.72% | — |
Return on capital | -248.62% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.69M | -6.90% |
Cash from operations | -1.10M | — |
Cash from investing | -1.21M | — |
Cash from financing | 2.61M | — |
Net change in cash | 301.39K | — |
Free cash flow | -1.74M | — |
About
Founded
1996
Headquarters
Website
Employees
4
